The emergence of nanopore-based sequencers greatly expands the reach of sequencing into low-resource field environments, enabling in situ molecular analysis. In this work, we evaluated the performance of the MinION DNA sequencer (Oxford Nanopore Technologies) in-flight on the International Space Station (ISS), and benchmarked its performance off-Earth against the MinION, Illumina MiSeq, and PacBio RS II sequencing platforms in terrestrial laboratories. Samples contained mixtures of genomic DNA extracted from lambda bacteriophage, Escherichia coli (strain K12) and Mus musculus (BALB/c). The in-flight sequencing experiments generated more than 80,000 total reads with mean 2D accuracies of 85 -90%, mean 1D accuracies of 75 -80%, and median read lengths of approximately 6,000 bases. We were able to construct directed assemblies of the ~4.7 Mb E. coli genome, ~48.5 kb lambda genome, and a representative M. musculus sequence (the ~16.3 kb mitochondrial genome), at 100%, 100%, and 96.7% pairwise identity, respectively, and de novo assemblies of the lambda and E. coli genomes generated solely from nanopore reads yielded 100% and 99.8% genome coverage, respectively, at 100% and 98.5% pairwise identity. Across all surveyed metrics (base quality, throughput, stays/base, skips/base), no observable decrease in MinION performance was observed while sequencing DNA in space. Simulated runs of in-flight nanopore data using an automated bioinformatic pipeline and cloud or laptop based genomic assembly demonstrated the feasibility of real-time sequencing analysis and direct microbial identification in space. Applications of sequencing for space exploration include infectious disease diagnosis, environmental monitoring, evaluating biological responses to spaceflight, and even potentially the detection of extraterrestrial life on other planetary bodies.
Introduction
The ability to sequence DNA off-planet would address a critical need for ensuring crew health and safety during space exploration missions. Durations for Mars missions are likely to range from 18 to 36 months, with 12 to 18 months of that time spent in transit between the planets, based on current propulsion technologies. Considering the time required to reach Mars and that feasible launch windows for Mars only occur every 26 months due to orbital dynamics, intervention from Earth during the course of a Mars mission will be limited to electronic communication. It is also known, though not well understood, that the human immune response becomes depressed in response to spaceflight (1), and gene expression-modulated increases in microbial virulence have been observed (2) . Thus, there is a clear need for in-flight diagnostic capability to ensure that any infections that arise are treated appropriately, including determining whether or not antibiotics should be administered, and if so, which ones (e.g., anti-fungal, antiviral, anti-microbial). Beyond the transcription level changes observed for microbes, it is also unknown how microbial populations will change over the course of a multi-year mission with increased exposure to ionizing radiation and microgravity during transit, both in terms of population ecology and genetic mutations. What is known, however, is that microbiome changes can have significant effects on human health on Earth. There is also the possibility that, if life ever existed on Mars, it could share a common ancestry with DNA-based life on Earth. If so, sequencing genetic material extracted from Mars would be the surest way to determine whether any DNA detected was contamination from Earth or if it was in fact from indigenous life on Mars.
Sequencing is the only currently existing technology that could be used to address all of these questions (disease diagnosis, population metagenomics, gene expression changes, accumulation of genetic mutations, and characterization of life on another planetary surface), 4 potentially with a single instrument. The commercially available MinION™ DNA sequencer (Oxford Nanopore Technologies, Oxford, UK) is small (9.5 × 3.2 × 1.6 cm) and lightweight (86 grams). Power and data transfer occur through a single USB connection to a computer or tablet, making the MinION exceptionally suited for use in remote locations, including space (3, 4) . To evaluate the performance of the MinION in a relevant space environment, we tested it aboard the International Space Station (ISS). Orbiting 400 km above the Earth and travelling at 28,000 km/h, the ISS is in constant freefall and maintains a continuous microgravity environment. In addition to being testbed for technology to be used in space, the ISS shares many features with remote environments on Earth, such as limited power capacity, re-supply only through extraordinary and costly efforts, and limitations on equipment and supplies requiring specific characteristics in ruggedness and size. Here we describe the results of nanopore DNA sequencing experiments performed aboard the ISS on samples containing a mixture of genomic DNA extracted from a virus (Enterobacteria phage lambda), a bacterium (Escherichia coli), and a host organism (mouse). In parallel, we performed control experiments on the ground and made cross-platform comparisons with genomic sequence data obtained from the same samples on Illumina MiSeq (Illumina, San Diego, CA) and PacBio (Pacific Biosciences, Menlo Park, CA) instruments.
Simulated analyses of in-flight data using an automated metagenomic pipeline and de novo genomic assemblies on the cloud and laptop demonstrate the feasibility of on-board, real-time analysis and assembly for future sequencing applications in space.
Results

Flight and Ground Control sequencing with the MinION
We launched the MinION to the ISS to evaluate its functionality in the microgravity environment, under the payload mission name "Biomolecule Sequencer". Four Biomolecule Sequencer experiments were conducted, on August 26th, September 3rd, September 7th, and September 13th, 2016 ( Supplementary Table 1 ). Identical, simultaneous sequencing runs were performed on the ground to mitigate variables not directly related to spaceflight and allow comparisons to the spaceflight-generated sequence data and performance metrics of the MinION device. For each run, a frozen sample containing ready-to-sequence DNA libraries was thawed and loaded on a new MinION flow cell, and the sequencing run was initiated using MinKNOW software (Oxford Nanopore Technologies, Inc.). All samples contained equimolar inputs of lambda, E. coli and mouse genomic DNA. A total of six distinct 6-hour sequencing runs (three inflight and three on the ground) from a single bulk sequencing library preparation, and two 48-hour runs (one in-flight and one on the ground) from a second library preparation were performed. Of the eight runs, all but one (ground control #2) produced good yields of high quality sequencing data. Upon completion of sequencing in-flight, all FAST5/HDF files produced were downloaded from the ISS to Earth. The flight and ground data were then analyzed using a number of opensource and custom-developed bioinformatic workflows (see Materials and Methods).
A key determinant of the success or failure of sequencing on the MinION is the number of active pores identified during the MUX scan performed at the initiation of sequencing. Previous vibration testing on the ground suggested that at least ~70% of nanopores in the R7 flow cells should be active after launch vibration (5) . Though there was considerable variability in the number of active pores, no statistically significant decrease in the number of active pores in the 6 flow cells used on the ISS was observed compared with the ones used on the ground (Supplementary Table 1 ). The low number of reads during the Ground Control #2 run was not unexpected considering the low number of available pores (n=215). A total of 89,693 reads (containing > 1 billion events), as determined from the totals displayed in the MinKNOW software at the end of each run, were generated across the four ISS experiments, compared with 51,392 from the ground controls. This suggests that MinION sequencing performance on the ISS was comparable to that on the ground. Initial quality control of the data was conducted using a custom Metrichor workflow for 1D and 2D basecalling and species identification ( Figure S1 ). We performed additional characterization of the in-flight and ground reads by analyzing the k-mer current plots across the four sets of runs ( Figure 1 ), as well as measurements of signal parsing quality with the skips/base ( Figure S2 ) and stays/base ( Figure S2 ). With the exception of ground control #2, the k-mer current profiles, skips/base, and stays/base were within the range of expected values for MinION sequencing and permitted adequate base-calling. We next analyzed the 1D and 2D accuracies of the in-flight and ground reads, along with organisms' identification from the read data ( Figure 2 ).
In general, read accuracies across the ISS and ground runs were comparable, spanning a median of 74-80% (ISS) and 71-78% (ground) median base accuracy for the 1D reads and 83-92% (ISS) and 80-90% (ground) median base accuracy for the 2D reads, though in most cases the accuracies of the in-flight reads were slightly higher. The distributions of reads in both the flight and ground data were found to be fairly evenly distributed across the E. coli genome (Supplementary Figures 3 and 4); median read lengths were typically 5,000 -6,000 bases (Supplementary Figure 5 ).
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Benchmarking of the MinION sequencing data against MiSeq and PacBio RSII data
To assess the accuracy of the ISS / ground nanopore MinION data and to establish "gold standard" genomic references for the lambda and E. coli genomes, we used the same stock of DNA for replicate sequencing experiments on PacBio RSII and the Illumina MiSeq instruments. We ran 22 SMRT cells across independently sequenced lambda, E.coli, and mouse genomic DNA samples on the RSII (1.1M reads with 11,366bp average length) and a full flow cell on the MiSeq Figure 3B ), while directed assembly of E. coli Illumina reads to the most closely matched genome in the NCBI nt reference database (E. coli K-12, CP014348) resulted in 99.0% coverage at 99.97% identity ( Figure 3C ). Similarly, genomic assemblies of the lambda genome from PacBio and Illumina data showed 100% concordance. Thus, two orthogonal sequencing methods were used to establish the E. coli and lambda genomic references for assessing the accuracy of in-flight and ground nanopore data. A direct alignment of the 2D reads to the de novo assembled genomes showed a median 89% and 86% agreement on base calling for the in-flight and ground data, respectively. Overall, we found that the longest molecule from the MinION matched well (90%) to the MiSeq and RSII data, showing that the long, phased genetic data from the MinION is likely amenable to use in analysis of the sequences generated on the ISS.
Accuracy and distribution of in-flight nanopore sequencing reads
The performance of ISS nanopore sequencing runs 1 through 3 were similar, with total yields of 15,000 to 18,000 reads and a relatively lower proportion of lambda reads relative to E. coli and mouse reads ( Figure 3D and 3E). Unlike the earlier runs, which were sequenced for 6 hours, in-flight run 4 was sequenced for 48 hours, more than doubling the number of reads.
Interestingly, the percentage of lambda reads generated from ISS run 4 was 22.9% versus an average of 8.8% in the first 3 runs, and the relative proportions of lambda, mouse, E. coli reads were very close to the predicted proportions of 33%/33%/33% that would be expected from sequencing of an equimolar mixture of genomic DNA. For all four runs, approximately one-third of reads were not identified as either lambda, E. coli, or mouse, likely due to single-read error rates of 8-20% on the R7 version of flow cells we used ( Figure 2 ). To gauge the improvement of the latest chemistry (R9) for the MinION, we ran an additional equimolar mixture of the three samples on Earth, and we found that the error rates of the latest chemistry, as expected, were indeed lower (5-10%). In contrast, 99.9% of the Illumina reads were properly assigned to one of the 3 organisms ( Figure 3E , right), although the relative proportions were less uniform than for flight run #4.
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Metagenomic analysis of in-flight nanopore data using the automated SURPIrt pipeline
To demonstrate the feasibility of analyzing sequencing data on the ISS, we ran simulations of real-time metagenomic analysis from in-flight nanopore data using the automated SURPIrt pipeline ( Figure 4A ). Developed at University of California, San Francisco (UCSF) as a hybrid of two previously published software pipelines, SURPI (6) and Metapore (7), SURPIrt is a bioinformatic pipeline for real-time pathogen detection and genomic characterization from metagenomic nanopore sequencing data. Species-specific reads corresponding to M. musculus, E. coli, and lambda from the sample mixtures were initially identified in SURPIrt within 1 minute of beginning sequence analysis by MegaBLAST alignment (word size = 16; e-value=1x10^-5). The distribution of detected reads were visualized in real-time as donut charts on a web browser refreshed every 30 s ( Figure 4B ; Supplementary Video 1).
Despite the average error rates of the individual nanopore reads, the vast majority of reads (>95%) were correctly identified to the species level ( Figure 4B ). Taxonomic classification using a lowest common ancestor (LCA) algorithm (a configurable parameter in SURPIrt), while improving specificity, resulted in fewer identified species-specific reads overall, and no lambda reads were detected ( Figure 4C , subgroups 1 and 2). The latter finding was attributed to the presence of a lambda prophage insertion in some E. coli reference genomes; separate classification of viral and bacterial taxa restored detection of a fraction of the missing lambda reads ( Figure 4C Strikingly, the relative proportion of identified lambda reads in the nanopore data was strikingly much less than that observed in the mouse or E. coli data ( Figure 4C , subgroups 1-3), despite preparation of the sample DNA genomes in equimolar concentrations. This finding was attributed to the presence of the integrated lambda prophage, as long nanopore reads containing 10 lambda insertion sites would be preferentially assigned to E. coli rather than lambda. A more uniform distribution of mouse, E. coli, and lambda reads was observed when nanopore reads were aligned to the closests matched target genome identified by SURPIrt using GraphMap, after ensuring that only single reads were mapped and that lambda sequences were excluded from the set of reads aligning to E. coli ( Figure 4C Figure 5D ).
De novo genome assembly across the sequencing platforms
To determine if the in-flight nanopore data generated on the ISS could be used for successful de novo assembly of the E. coli genome, we independently tested two state-of-the-art genome assemblers from nanopore reads, Miniasm (9) and Canu (https://github.com/marbl/canu).
For the Miniasm assembly, we first filtered out the host reads (mouse) from the ISS data, to leave only those from E. coli and lambda. We then used the Miniasm genome assembler followed by nanopolish (https://github.com/jts/nanopolish) to assemble and correct the genome, creating a total of two contigs: 1,636,060bp and 3,042,754 bp. These two contigs add to a total of 4.697 Mb out of an expected size of 4.734 Mb based on the PacBio assembly (98.8% complete), with 97.33% accuracy relative to the PacBio reference genome.
Next, we ran Canu on both a computational server and a laptop to perform successive de novo assemblies from nanopore sequencing data corresponding to (i) in-flight runs 1-4, (ii) inflight runs 1-4, (iii) in-flight runs 1-4 after computational subtraction of mammalian "host" reads corresponding to mouse genome, and (iv) in-flight runs after filtering for reads matching bacteria ( Figure 5B ). Overall, assemblies were accurate, >99% complete with >98.3% pairwise identity relative to the PacBio reference genome. Although Miniasm had significantly faster run time than Canu (<1 minute versus 2 hours on a 64-core server), Canu appeared to be more accurate, with more complete genomes and improved accuracy relative to Miniasm. De novo assembly of nanopore reads using Canu resulted in 100% coverage at 98.5% pairwise identity, an impressive performance despite the presence of a small misassembly in one of the four contigs.
We further tested the ability to run these assemblies not only on computational servers but also on the cloud (the Amazon Elastic Compute Cloud / EC2 platform) and on a laptop. We observed that an 8-core, 32 Gb EC2 instance was sufficient to complete an entire Miniasm assembly within 15 seconds, and a similarly configured laptop with 8 hyperthreaded cores and 64 Gb RAM took 40 sec ( Supplementary Figure 7) . These results on the cloud and laptop show that ISS, spacecraft, and satellite-based, Earth-free genome sequencing and assembly are possible. As the lambda prophage is inserted into the E. coli genome, these data also constitute the first de novo assemblies of a complete bacterial and viral genome with 100% accuracy, and indeed, the first genome assemblies of any organism from sequence data generated solely off of planet Earth.
Discussion
Our results of the first-ever DNA sequencing in space indicate that the performance of the MinION sequencing platform was not adversely affected by transport to the ISS nor by loading or operation in its microgravity environment. The data obtained from sequencing aboard the ISS can readily recapitulate the measurements of nucleic acids from phages (lambda), bacteria (E. coli), and mammalian (mouse) DNA on Earth. Indeed, across all three species, the base quality and 2D read alignments were routinely above 85%, with equal or superior performance to the identical replicate libraries and flow cells tested on Earth. These results were also true when comparing the skips/base, stays/base, read length, and GC-content of the data. These sequence reads were also validated against sequencing data obtained on PacBio RSII and Illumina MiSeq instruments to confirm their accuracy and species identity.
Moreover, when using the data produced only from space for a de novo assembly, we observed that the E. coli reads were sufficient to generate a high-quality genome assembly (2 contigs, >98% identity) from both the Canu and Miniasm+nanopolish assemblers. Excitingly, these data demonstrate that a de novo assembly of microbial genomes from raw, unfiltered data containing interfering host background sequences (e.g. mouse genome) is possible. We tested assembler with the lowest computational requirements (Miniasm alone) on both a cloud-based platform (EC2) and also on a laptop. As with sequence data from any platform, the success of unfiltered assembly from nanopore reads will likely depend on the complexity of the metagenomic background in the sample, depth of sequencing, and sequencing error rates, which have been steadily decreasing over time for nanopores (10) . In aggregate, these current results clearly validate the future implementation of the MinION for rapid, in situ diagnostics and microbial identification on the ISS. 13 As exploration progresses beyond low Earth orbit toward extended missions in cis-lunar space and eventually to Mars, changes and advances in nanopore-based sequencing will be needed.
As communication delays increase and data transfer rates decrease, local analysis of sequencing data will be critical. Aspects of this challenge are manifested on Earth in remote locations and point-of-care settings of clinical and public health significance, such as "hot spots" from outbreaks due to Ebola or Zika virus (11) . In the current study, we used the SURPIrt platform to simulate an automated metagenomic analysis of nanopore data in real-time from read processing to microbial identification to genome assembly, and we also showed an entirely cloud-based, rapid (15sec) assembly was possible, highlighting the ability to use these tools and techniques for future missions.
The largest outstanding question for use of the MinION in deep space exploration is flow cell stability over the course of an 18 to 36 month mission. Factors such as extreme temperatures and increased galactic and cosmic radiation exposure are less of a concern for flow cell stability during human missions as crew members will need to be shielded from these conditions as well.
For robotic missions, however, enhancements a greater degree of ruggedization will be needed. Nanopore sequencing that involves the direct analysis of DNA, rather than indirect products of 14 sequencing-by-synthesis, has been used to detect base modifications in DNA (12, 13) , and also to sequence RNA (14) . Direct nanopore analysis has even been used for proteins (15) . The ability of nanopore analyzers to accommodate a range of polymers increases the chance of detecting extraterrestrial life, which could use different bases or sugars in its genetic material beyond canonical AGCT/U DNA and RNA, greatly increases the value they offer for life detection technology.
In the more immediate future, the MinION holds the potential to greatly improve the rate at which ISS research can be performed by allowing researchers rapid access to data obtained inflight, rather than having to wait for sample return. With robust experiment planning and some foresight, research projects that required multiple flights over several years could now be performed in a matter of months, as researchers could monitor experiment progress and make adjustments as needed (i.e., cadence of timepoints, identifying a subset of samples that should be returned to Earth for further analysis etc.). Studies of gene expression in-flight would also be enabled by a sequencing platform on the ISS, and could be performed more robustly and with less risk of experiment failure by reducing the need for storage of labile RNA in a freezer, eliminating time constraints posed by organism re-acclimation upon return to Earth, and facilitating more optimal and less arbitrary selection of time-points for sample collection and analysis.
Conclusion
The observation that the MinION sequencing platform performed equally well (or better) on orbit than it did on the ground without any modifications for spaceflight highlights the potential 
Materials and Methods
Spaceflight Hardware
The 
Library Preparation and Sequencing
Samples analyzed in this study contained sequence libraries prepared from mixtures of female mouse BALB/C (Zyagen, San Diego, CA), Escherichia coli K-12 (Zyagen), and N 6 -methyladenine-free bacteriophage lambda (New England Biolabs, Ipswich, MA) genomic DNA.
These species were chosen based on their being model mammal, bacterium, and virus, respectively. The samples were aliquoted for library preparation on three platforms: Oxford Nanopore Technologies (ONT) MinION (v6), Illumina MiSeq (v2), and the Pacific Biosciences RSII.
MinION Library Preparation and Sequencing (Ground and ISS)
Aliquots of DNA for mouse, E. coli, and lambda libraries were sheared individually using was then prepared for sequencing according to Oxford Nanopore Technologies' procedure for the SQK-MAP-006 Kit. Following library preparation, individual samples were mixed with a 102 ng aliquot of pre-sequencing library (150 µl) with 162.5 µl of 2X running buffer, 6.5 µl fuel mix (Oxford Nanopore Technologies) and 156 µl molecular-grade sterile deionized water to a total volume of 450 µl. This volume was loaded into a 1 ml syringe and the syringe was capped. A total of 18 samples were prepared: nine flight samples and nine ground control samples. Capped syringes containing the samples were packaged with an identical 1 ml syringe for potential bubble removal and syringe tips were placed inside of a large plastic tube to facilitate transport. After syringe loading, the tubes were stored at -80 °C.
Ground Processing of Cold Stowage Hardware
The nine flight samples were removed from the -80 °C freezer, placed on dry ice in a Styrofoam cooler, and shipped overnight to the launch processing facility at Kennedy Space Center (KSC). Once at KSC, the samples were maintained in a -80 °C freezer until transfer to the powered freezer on the SpaceX Dragon Capsule. To more closely approximate the handling of the flight samples, the nine ground control samples were also removed from the freezer, placed on dry ice in a Styrofoam cooler and allowed to sit on the laboratory bench for the same amount the time that the flight samples were out of the freezer during transit. Eighteen total R7.3 flow cells from the same manufacturing lot were shipped directly from the manufacturer to KSC for flight (9) and JSC to serve as ground controls (9) . Upon receipt, the flow cells were stored at +4 °C until the time of launch. The flow cells and samples were maintained within the launch processing labs at KSC until 48 h before the launch, at which point they were loaded onto the vehicle.
Launch and ISS Stowage Conditions
Flow cells were launched in a double cold bag in which the temperature was maintained between + 2 and + 8 °C. The DNA samples were launched in a powered freezer in which temperatures were maintained between -80 and -90 °C. Upon docking with the ISS, the flow cells and DNA samples were transferred to refrigerator (+2 to +8 °C) and freezer (-80 to -90 °C) dewars within the Minus Eighty Degree Laboratory Freezer for ISS (MELFI), respectively. All other items were stored at ambient ISS conditions. 
Sequencing Experiments
PacBio RSII Library Preparation and Sequencing
Single Molecule, Real-Time (SMRT) sequencing libraries were prepared using the SMRTbell Template Prep Kit 1.0 (Pacific Biosciences) and 20 kb Template Preparation Using BluePippin Size-Selection System protocol (Pacific Biosciences). 5 μg of each sample were used. Library quality and quantity were determined using an Agilent 2200 TapeStation and Qubit dsDNA BR Assay (Life Technologies), respectively. Sequencing was conducted using P6-C4 chemistry and a v3 SMRT Cell (Pacific Biosciences) at Weill Cornell Medicine.
Illumina MiSeq Library Preparation and Sequencing
Sequencing libraries were prepared from 1 ng of sample using the NexteraXT kit (Illumina) according to the manufacturer's protocol. Libraries were indexed with dual 8-nt barcodes on each end of the sequencing amplicon. In total, 4 dual-indexed DNA sequencing libraries were constructed, corresponding to lambda bacteriophage, E. coli, mouse, and an equimolar mixture of DNA from the 3 organisms. Libraries were quantitated using the Agilent Bioanalyzer and Qubit spectrophotometer and sequenced on an Illumina MiSeq as a 1 x 160 base pair (bp) single-end sequencing run. The approximate percentage of the run allocated to each library as determined by the quantified input concentration was 3% for lambda bacteriophage, 17% for E. coli, 30% for mouse, and 50% for the equimolar mixture.
Data Analysis Basecalling
Basecalling was performed using the Metrichor workflow "2D Basecalling for SQK-MAP006 -v1.107".
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Read Selection
We used a custom shell script to extract one read from each fast5 file for further quantification and analysis, selecting the 2D read where available, and the higher quality of the 1D template or complement read where not.
GraphMap and Calculation of Species Counts / Proportions
As described in previously (5) , we aligned to a combined Enterobacteria lambda phage (NCBI reference sequence NC_001416.1), Escherichia coli (NCBI reference sequence 
De novo genome assembly from PacBio and Illumina data
To ensure that our E. coli alignments and sequencing measures were not a result of any strain or sample-specific genetic drift or contamination, we performed a de novo assembly of the 21 E. coli genome used in this study using the PacBio data. We used the Hierarchical Genome Assembly Process (HGAP, v2) for read-cleaning and adapter trimming (pre-assembly), de novo assembly with Celera Assembler, and assembly polishing with Quiver (18) . Raw sequencing reads were filtered for length and quality such that the minimum polymerase read score was 0.8, the minimum subread length was 500 bp, and the minimum polymerase read score was greater than 100. The assembly was generated using CeleraAssembler v1 with the default parameters and was polished using the Quiver algorithm (18) . Our assembly yielded a single contig of 4,734,145 base pairs at >99.7% accuracy and confirmed the E. coli sample as strain K-12.
We next performed independent de novo and directed assemblies of the E. coli genome using single-end Illumina data. Raw Illumina reads were preprocessed for trimming of adapters and removal of low-complexity and low-quality sequences. E. coli reads were identified using Bowtie2 alignment against the E. coli reference genome in local alignment mode at default parameters. De novo assembly was performed using the SPAdes genome assembly v3.8.2 (19) with the "careful" parameter. The de novo assembled contigs as well as the original dataset of Illumina reads were then separately mapped to the consensus PacBio E. coli genome assembly.
SURPIrt (sequence-based ultra-rapid pathogen identification, real-time) analysis
The SURPIrt pipeline is a real-time analysis pipeline for automated metagenomic pathogen detection and reference-based genomic assembly from nanopore sequencing data. Consisting of an amalgam of previously published SURPI (6) and Metapore (7) software, and a newly developed musculus reference genome. Non-host reads were then aligned to the comprehensive NCBI nt database, which contains GenBank, for identification of viruses, bacteria, fungi, and parasites, respectively. For each read, the single best match by e-value was retained, and the corresponding NCBI Genbank identifier (gi) assigned to the best match was then annotated by taxonomic lookup of the corresponding lineage, family, genus, and species. We tested various configurations of the SURPIrt pipeline, including the incorporation of taxonomic classification according to lowest common ancestor (7) using either the viral and bacterial portions of the NCBI nt database or the entire NT database.
For automated real-time results visualization (7), a live taxonomic count table was generated by SURPIrt and displayed as a donut chart using the CanvasJS graphics suite (http://canvasjs.com/, accessed September 26 th , 2016) with the chart refreshing every 30 s. For each microbial species detected, the top hit was chosen to be the reference gi in the NCBI nt database (among all reference sequences assigned to that species) with the highest number of aligned reads, with priority given to reference sequences in the following order: (1) complete genomes, (2) complete sequences, or (3) partial sequences or individual genes. Metagenomic heat maps, Krona plots (8), coverage maps, and pairwise identity maps were automatically generated using SURPIrt for viewing via the SURPIviz graphical user interface.
For purposes of comparison, more complete coverage maps were generated by GraphMap alignment to the SURPIrt-identified top species gi, and then visualized using SURPIviz. In future iterations of SURPIrt, a separate computational analysis fork to run GraphMap alignment in realtime will be automatically spawned from species-level "hits" containing a number of reads exceeding a preset threshold.
De novo genome assembly from nanopore data
We used Minimap v0.2-r124-dirty and Miniasm v0.2-r137-dirty as described in the github tutorial, using 8 threads (https://github.com/lh3/miniasm). Two assemblies were generated, using reads that mapped exclusively to Escherichia coli K12 MG1655 using GraphMap from the four runs on the ISS, and all reads from the ISS that did not map to host organisms (human and mouse, using genomes hg38 and mm10). We then polished these assemblies using nanopolish v0.5.0. We used Canu v1.73 (20) at default parameters using a specified target genome size of 4.8 MB to de novo assemble contigs directly from in-flight nanopore data corresponding to the "metagenomic" 24 mixture of mouse, E. coli, and lambda genomes. Runs were performed using both a 64-core computational server with 512 gigabytes (Gb) memory and an 8-hyperthreaded core laptop with 64 Gb memory. Four sets of de novo assemblies were generated: (1) in-flight runs 1-3 (n=46,871), Assembly metrics, including N50, were calculated by the "abyss-stats.pl" program in ABySS (21) .
E. coli were mapped to the consensus PacBio genome using Mauve version 2.4.0 (22) . Genomewide pairwise identities of de novo assemblies were estimated using JSpeciesWS (23) after specifying the use of MUMmer (24) for pairwise identity calculations. 
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